Global Strep Throat Treatment Drugs Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Strep Throat Treatment Drugs Market Research Report 2024
Penicillin or amoxicillin is the antibiotic of choice to treat group A strep pharyngitis. There has never been a report of a clinical isolate of group A strep that is resistant to penicillin. However, resistance to azithromycin and clarithromycin is common in some communities.
According to Mr Accuracy reports’s new survey, global Strep Throat Treatment Drugs market is projected to reach US$ 2698.4 million in 2029, increasing from US$ 1986 million in 2022, with the CAGR of 4.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Strep Throat Treatment Drugs market research.
The strep throat treatment drugs market is driven by the prevalence of streptococcal infections and the need for effective treatment options. Strep throat is a common bacterial infection caused by Streptococcus bacteria, affecting millions of people worldwide. The rise in the incidence of strep throat and its potential complications, such as rheumatic fever and kidney damage, contribute to market growth. The market is propelled by the development of new and improved antibiotics and other therapeutics targeting streptococcal infections. However, the market also faces challenges, including antibiotic resistance, which poses a threat to treatment efficacy. Additionally, the difficulty in distinguishing between strep throat and viral infections, as well as the overuse of antibiotics, can pose obstacles for accurate diagnosis and appropriate treatment selection. To succeed, companies must focus on research and development to combat antibiotic resistance, collaborate with healthcare providers to improve diagnostic accuracy, and work towards providing targeted and effective strep throat treatment drugs to meet the increasing demand for effective therapeutic options.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Strep Throat Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merck & co.
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
Astra Zeneca
Bayer
Bausch Health
Segment by Type
Penicillin
Amoxicillin
Hospitals
Specialty Clinics
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Strep Throat Treatment Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Strep Throat Treatment Drugs market is projected to reach US$ 2698.4 million in 2029, increasing from US$ 1986 million in 2022, with the CAGR of 4.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Strep Throat Treatment Drugs market research.
The strep throat treatment drugs market is driven by the prevalence of streptococcal infections and the need for effective treatment options. Strep throat is a common bacterial infection caused by Streptococcus bacteria, affecting millions of people worldwide. The rise in the incidence of strep throat and its potential complications, such as rheumatic fever and kidney damage, contribute to market growth. The market is propelled by the development of new and improved antibiotics and other therapeutics targeting streptococcal infections. However, the market also faces challenges, including antibiotic resistance, which poses a threat to treatment efficacy. Additionally, the difficulty in distinguishing between strep throat and viral infections, as well as the overuse of antibiotics, can pose obstacles for accurate diagnosis and appropriate treatment selection. To succeed, companies must focus on research and development to combat antibiotic resistance, collaborate with healthcare providers to improve diagnostic accuracy, and work towards providing targeted and effective strep throat treatment drugs to meet the increasing demand for effective therapeutic options.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Strep Throat Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck & co.
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
Astra Zeneca
Bayer
Bausch Health
Segment by Type
Penicillin
Amoxicillin
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Strep Throat Treatment Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices